Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Radio Frequency Identification (RFID) In Pharmaceuticals Market Heading Into 2029?

The size of the market for radio frequency identification (RFID) in pharmaceuticals has seen rapid growth in recent years. It’s projected to rise from $5.48 billion in 2024 to $6.08 billion in 2025, accumulating a compound annual growth rate (CAGR) of 10.9%. The growth experienced in the past can be credited to factors such as increased pharmaceutical exports, a surge in e-commerce, an uptick in clinical trials, a growing demand for RFID solutions that show clear evidence of tampering, and an increase in healthcare delivery models that prioritize the patient.

The market size of radio frequency identification (RFID) in pharmaceuticals is predicted to witness swift expansion in the upcoming years, and is expected to reach $9.12 billion by 2029, with a compound annual growth rate (CAGR) of 10.7%. This growth during the projected period can be ascribed to escalating instances of fake drugs, greater awareness about healthcare, escalation in hospital automation, increased need for real-time monitoring, and surging investment in digital delivery network solutions. Foremost trends for the projected period include progress in technology, advancements in RFID tag design, incorporation with cloud-based platforms, innovation in pharmaceutical-specific inlays, and improvements in the digitization of the supply chain.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25891&type=smp

Which Factors Are Pushing The Radio Frequency Identification (RFID) In Pharmaceuticals Market Forward?

The growth of the radio frequency identification (RFID) in pharmaceuticals market is being spurred on by the rising instances of counterfeit drugs. Counterfeit medicines are deceptively mislabeled pharmaceutical products, either in their identity or source. There has been a sharp upswing in these fake drugs primarily due to the proliferation of online pharmacies, enabling counterfeiters to bypass traditional regulatory checks and disseminate counterfeit medication more easily, making its detection more challenging. The RFID in pharmaceuticals combats against counterfeit drugs by providing secure, traceable data that confirms the product’s authenticity at each step of the supply chain. As an example, the American Chemical Society, a scientific society based in the US, stated that in December 2024, there was 6,987 counterfeit drug incidents reported across 142 countries in 2023, indicating a 4% surge from 2022. Consequently, the escalating incidences of counterfeit drugs are fueling the growth of the RFID in pharmaceuticals market.

Which Segment Held The Largest Share In The Radio Frequency Identification (RFID) In Pharmaceuticals Market In 2025?

The radio frequency identification (rfid) in pharmaceuticals market covered in this report is segmented –

1) By Type: Chipped Radio Frequency Identification, Chipless Radio Frequency Identification

2) By Component: Radio Frequency Identification Tags, Radio Frequency Identification Readers, Middleware Software, Integration Services, Data Management Software

3) By Regulatory Compliance: Food And Drug Administration Compliance Standards, European Union Falsified Medicines Directive, Good Distribution Practices, Serialization Requirements, Tracking And Tracing Regulations

4) By Application: Drug Track And Trace System, Asset Tracking, Patient Safety, Other Applications

5) By End-User: Pharmaceutical Manufacturers, Hospitals And Healthcare Providers, Pharmacies And Drug Wholesalers, Research And Development Laboratories, Logistics And Supply Chain Companies

Subsegments:

1) By Chipped Radio Frequency Identification, By Type: Low Frequency Radio Frequency Identification, High Frequency Radio Frequency Identification, Ultra High Frequency Radio Frequency Identification, Active Radio Frequency Identification, Passive Radio Frequency Identification, Semi-Passive Radio Frequency Identification

2) By Chipless Radio Frequency Identification, By Type: Time Domain Reflectometry, Frequency Domain Reflectometry, Magnetic Resonance-Based Tags, Surface Acoustic Wave Tags, Printed Conductive Polymer Tags, Photonic Band Gap Structures

What Future Market Trends Are Projected For The Radio Frequency Identification (RFID) In Pharmaceuticals Industry?

Leading companies within the radio frequency identification (RFID) sector of the pharmaceutical industry are putting increased focus on creating advanced RFID-capable labels. These innovation aims to boost the traceability of products, streamline inventory control, and act as a deterrent to counterfeit drugs. These smart tags, enabled by RFID, use radio frequency technology to wirelessly track and authenticate pharmaceutical products throughout the supply chain. As an illustration, in May 2023, the German pharmaceutical company, Fresenius Kabi AG, introduced the Rocuronium Bromide Injection which includes advanced RFID-capable labels. This enhancement was designed to improve medication tracking, inventory control, and patient safety within healthcare facilities. It comes in a 50mg per 5mL multiple-dose vial for intravenous administration by certified medical personnel. The injection is equipped with advanced RFID smart labels, ensuring real-time tracking, efficient inventory control, and decreased medication mistakes.

Which Organizations Are Driving Progress In The Radio Frequency Identification (RFID) In Pharmaceuticals Industry?

Major companies operating in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, identytag GmbH & Co KG

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-in-pharmaceuticals-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Radio Frequency Identification (RFID) In Pharmaceuticals Industry?

North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radio frequency identification (rfid) in pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25891&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model